Comparison of in vivo and post-mortem small-intestinal lengths of rats: Implication in absorption prediction

Biopharmaceutics and Drug Disposition

Volumn 18, Issue 3, 1997, Pages 271-275

  Choi, Young M ^a   Chiou, Win L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

in vivo and post mortem small intestinal length; intestinal absorption

Indexed keywords

ANIMAL TISSUE; ARTICLE; DEATH; DRUG ABSORPTION; IN VIVO STUDY; INTESTINE ABSORPTION; NONHUMAN; RAT; SMALL INTESTINE;

EID: 0030932285     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199704)18:3<271::AID-BDD16>3.0.CO;2-I     Document Type: Article

References (14)

1. I. Komiya, J. Y. Park, A. Kamani, N. F. H. Ho and W. I. Higuchi, Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model drug. Int. J. Pharm., 4, 249-262 (1980).
2. R. J. Sawchuk and W. M. Awni, Absorption of cyclosporine from rabbit small intestine in situ. J. Pharm. Sci., 75, 1151-1156 (1986).
3. F. H. Hsu, T. Prueksaritant, M. G. Lee and W. L. Chiou, The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: extrapolation to human data based on the body surface area concept. J. Pharmacokinet. Biopharm., 15, 369-386 (1987).
4. G. L. Amidon, Determination of intestinal wall permeabilities. In Animal Models for Oral Drug Delivery in Man: In Situ and In Vitro Approaches, W. Crouthamel and A. C. Sarapu (Eds), American Pharmaceutical Association, Washington, DC, 1980, pp. 1-25.
5. G. L. Amidon, P. J. Sinko and D. Fleisher, Estimating human fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res., 5, 651-654 (1988).
6. J. B. Dressman and K. Yamada, Animal models for oral drug absorption. In Pharmaceutical Bioequivalence, P. Welling and F. L. Tse (Eds), Dekker, New York, 1991, pp. 235-266.
7. W. L. Chiou, Determination of drug permeability in a flat or distended stirred intestine: Prediction of fraction dose absorbed in human after oral administration. Int. J. Clin. Pharmacol. Ther., 32, 474-482 (1994).
8. W. L. Chiou, Effect of 'unstirred' water layer in the intestine in the rate and extent of absorption after oral administration. Biopharm. Drug Disposit., 15, 709-717 (1994).
9. G. L. Amidon, H. Lenneräs, V. P. Shah and J. R. Crison, A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 12, 413-420 (1995).
10. T. T. Kararli, Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Disposit., 16, 351-380 (1995).
11. B. M. L. Underhill, Intestinal length in man. Br. Med. J., 4950, 1243-1246 (1955).
12. R. Nickel, Über die Ermittlung der Länge and Lage des Verdauungskanals. Z. Ges. Exp. Med., 91, 193-243 (1933).
13. J. Hirsch, E. H. Ahrens, Jr and D. H. Blankenhorn, Measurement of the human intestinal length in vivo and some causes of variation. Gastroenterology, 31, 274-284 (1956).
14. G. Ganter, Über die Länge des menschlichen Darmes. Z. Ges. Exp. Med., 48, 561-569 (1925-6).